Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (401-410 of 443) with videos related to

Pageof 45
Sort By:
Cancer Research|April 6, 2007
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancersStuart C Winter, Francesca M Buffa, Priyamal Silva, et al.
Journal of the National Cancer Institute|March 29, 2013
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanomaChristy C Ong, Adrian M Jubb, Diana Jakubiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancerMatteo Morotti, Esther Bridges, Alessandro Valli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2013
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancerAmanda Eustace, Navin Mani, Paul N Span, et al.
Molecular Cancer Therapeutics|August 10, 2019
Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer TherapyMassimo Masiero, Demin Li, Pat Whiteman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation seriesChristine Desmedt, Fanny Piette, Sherene Loi, et al.
The Journal of Biological Chemistry|December 13, 2002
Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancerPaul J Adam, Robert Boyd, Kerry L Tyson, et al.
Iscience|January 23, 2024
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expressionXiaodong Zhuang, Giulia Gallo, Parul Sharma, et al.
Cell Death & Disease|June 28, 2022
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiationChristos E Zois, Anne M Hendriks, Syed Haider, et al.
Cancer Research|November 29, 2017
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS DefenseMarina Pajic, Danielle Froio, Sheridan Daly, et al.
Pageof 45

Showing results (401-410 of 443) with videos related to

Sort By:
Pageof 45
Cancer Research|April 6, 2007
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancersStuart C Winter, Francesca M Buffa, Priyamal Silva, et al.
Journal of the National Cancer Institute|March 29, 2013
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanomaChristy C Ong, Adrian M Jubb, Diana Jakubiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancerMatteo Morotti, Esther Bridges, Alessandro Valli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2013
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancerAmanda Eustace, Navin Mani, Paul N Span, et al.
Molecular Cancer Therapeutics|August 10, 2019
Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer TherapyMassimo Masiero, Demin Li, Pat Whiteman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation seriesChristine Desmedt, Fanny Piette, Sherene Loi, et al.
The Journal of Biological Chemistry|December 13, 2002
Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancerPaul J Adam, Robert Boyd, Kerry L Tyson, et al.
Iscience|January 23, 2024
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expressionXiaodong Zhuang, Giulia Gallo, Parul Sharma, et al.
Cell Death & Disease|June 28, 2022
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiationChristos E Zois, Anne M Hendriks, Syed Haider, et al.
Cancer Research|November 29, 2017
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS DefenseMarina Pajic, Danielle Froio, Sheridan Daly, et al.
Pageof 45